MIND4-17 is a recently developed NF-E2-related factor 2 (Nrf2) activator, which uniquely causes Nrf2 disassociation from Keap1. Here, we showed that pretreatment with MIND4-17 significantly inhibited hydrogen peroxide (HO)-induced viability reduction of primary osteoblasts and OB-6 osteoblastic cells. Meanwhile, MIND4-17 inhibited both apoptotic and non-apoptotic osteoblast cell death by HO. MIND4-17 treatment induced Keap1-Nrf2 disassociation, causing Nrf2 stabilization, accumulation and nuclear translocation in osteoblasts, leading to transcription of several Nrf2-dependent genes, including and . Additionally, MIND4-17 largely attenuated HO-reactive oxygen species (ROS) production, lipid peroxidation and DNA damages. Nrf2 knockdown by targeted short hairpin RNA (shRNA) exacerbated HO-induced cytotoxicity in OB-6 osteoblastic cells, and nullified MIND4-17-mediated cytoprotection against HO. Meanwhile, Keap1 shRNA took over MIND4-17's actions and protected OB-6 cells from HO. Together, MIND4-17 activates Nrf2 signaling and protects osteoblasts from HO.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739668 | PMC |
http://dx.doi.org/10.18632/oncotarget.22360 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!